Therefore, the emphasis must be on families and less so on a single case or the proband. In a single individual, one at best could surmise the causal variant, although not with high certainty. B. nsSNVs. By changing the amino acid sequence in the protein, the nsSNVs are more likely to be pathogenic than the synonymous variants, although there might be exceptions. The vast majority of Inhibitors,research,lifescience,medical the 13,500 nsSNVs in each exome are unlikely to be pathogenic. C. Rare variants. Rare variants are more likely to be pathogenic than common variants for reasons that were discussed earlier. Common and uncommon variants that have a population frequency greater than the prevalence of the disease

are unlikely Inhibitors,research,lifescience,medical to be pathogenic. A variant that is absent in the databases and therefore considered novel is a stronger candidate. D. LoF variants. SNVs

that result in premature truncation of the encoded protein, such as stop codon mutations and frameshift variants, are stronger pathogenic variants. E. De novo variants. Variants that are present in the affected probands but absent in the healthy parents are strong candidates to be pathogenic. F. Functional rare variants in genes previously implicated in the pathogenesis of the phenotype. Inhibitors,research,lifescience,medical Rare nsSNVs in known causal genes for the phenotype are likely but not definitively causal in an index case. G. Common and uncommon variants – nsSNV or otherwise – previously shown to be associated with a common phenotype. The clinical impact of these variants is relatively modest. Clinically Guided Classification of the DSVS The algorithms used to NLG919 chemical structure identify the causal variants often do Inhibitors,research,lifescience,medical not result in a definitive isolation of the pathogenic variants but often provide a probable weight. To simplify the Inhibitors,research,lifescience,medical clinical decision making, we have classified the DSVs in the genome into five categories, as follows17: A. Disease-causing variants. These variants are rare in each genome/exome and are typically responsible for single-gene diseases. They are typically

missense, nonsense, or frameshift variants. When present, these variants cause the disease, although expressivity is variable and the major determinant of the why severity of the phenotype. Several other genetic and nongenetic factors also contribute to the phenotypic expression of the disease.19, 20 Identifying these variants through WES has the highest impact on the care of the individual and family. B. Likely disease-causing variants. These variants are typically rare LoF variants that are absent in the general population. However, despite being functional and rare or even exclusive to an individual or family, these variants do not show a perfect cosegregation, partly because of low penetrance.21, 22 These variants have the second largest effect sizes on the phenotype. C. Disease-associated variants.